Galil Ofek Innovation

Galil Ofek Innovation is a medtech incubator based in Katzrin in Israel’s Northern Periphery, backed by Clalit HMO. The Clalit relationship is the most important fact in the record: it gives portfolio companies access to clinical trial fields and patient data within Israel’s largest HMO, which is a structural advantage for any healthcare AI or device team that needs real-world clinical sites at the earliest stages. The firm carries a higher specialty score in the source data, reflecting that institutional access.

Stages are Pre-Seed and Seed, with check sizes between $250,000 and $1 million. Sub-verticals span medical devices, digital health, and biotech. The record does not list named portfolio companies. Geographic activity is concentrated in Israel, particularly the northern region.

For founders, Galil Ofek is one of the more interesting entries in this batch precisely because of the Clalit clinical access. Healthcare AI teams that need patient cohorts, real-world data, or early clinical pilots should weigh this access carefully. The geographic location in Katzrin requires founders to operate at least partly outside the Tel Aviv core, which can be a friction point but is usually offset by the clinical relationships. Israeli incorporation and willingness to engage with Clalit’s clinical workflows are essentially required to capture the structural value the incubator offers.